10-Q: Amesite Reports Reduced Losses, Strategic Pivot to Healthcare AI

Amesite Inc. significantly narrowed its net loss and increased revenue in Q1 2026, driven by a strategic shift to AI-driven healthcare solutions, despite ongoing 'going concern' doubts.

Summary

• Net revenue for the three months ended September 30, 2025, increased substantially to $94,296, up from $11,250 in the same period last year.
• The company reported a net loss of $(642,266) for the quarter, a significant improvement from a net loss of $(908,045) in the prior year period.
• Basic and diluted loss per share improved to $(0.14) from $(0.34) year-over-year.
• Total operating expenses decreased to $756,420 from $938,594, primarily due to lower payroll costs, professional fees, and reduced headcount in technology and administrative functions.
• Cash, cash equivalents, and restricted cash totaled $1,930,053 as of September 30, 2025, down from $2,433,418 at June 30, 2025.
• The company has pivoted its strategy, de-focusing on academic customers and now offering AI-driven solutions for the healthcare industry, with the NurseMagic™ app gaining traction.
• Management has concluded that there are conditions raising substantial doubt about the company's ability to continue as a going concern for the next twelve months, despite plans for future financing.

Sentiment

Score: 4

Explanation: While the company showed significant improvements in revenue growth and reduced losses, the explicit 'going concern' warning and reliance on uncertain future capital raises weigh heavily on the overall sentiment. The strategic pivot is positive, but the financial stability remains a major concern.

Positives

• Net revenue increased significantly by 738% to $94,296 for the three months ended September 30, 2025, compared to $11,250 in the prior year.
• Net loss decreased by 29.3% to $(642,266) for the quarter, demonstrating improved financial performance.
• Operating expenses were reduced across all categories, including general and administrative, technology and content development, and sales and marketing, leading to a 19.4% decrease in total operating expenses.
• The company's strategic pivot to AI-driven healthcare solutions, particularly the NurseMagic™ app, is gaining traction with larger entities.
• Cash used in operating activities decreased to $(415,765) from $(488,263), indicating improved operational efficiency in cash management.

Negatives

• The company continues to incur net losses and negative cash flows from operating activities, with an accumulated deficit of $(42,092,853) since inception.
• Management believes it may not have sufficient cash and cash equivalents to maintain planned operations for the next twelve months, raising substantial doubt about its ability to continue as a going concern.
• Future financing plans, which may include offerings of common stock, are subject to market conditions and are not deemed probable, and do not alleviate the substantial doubt about the company's going concern status.
• Cash and cash equivalents decreased by $503,365 during the quarter, from $2,433,418 to $1,930,053.
• The company relies on a single customer for 12% of its revenues for the current quarter, indicating customer concentration risk.

Risks

• Ability to deliver solutions that demonstrably offer meaningful return on investment (ROI) to customers.
• Ability to deliver its Site to customers at a price point that enables sufficient revenue generation for profitability.
• Ability to continue as a going concern due to a history of net losses and negative cash flows.
• Ability to obtain additional funds for operations, as current cash may not be sufficient for the next twelve months.
• Ability to obtain and maintain intellectual property protection for technologies and operate without infringing on others' intellectual property rights.
• Reliance on third parties to conduct business and studies, and to provide and maintain its Site.
• Ability to attract and retain qualified key management and technical personnel.
• Impact of government regulation and developments relating to competitors or the industry.
• Operating in an industry subject to rapid change, posing financial, operational, and technological risks.
• Significant concentration of credit risk primarily in cash, cash equivalents, and restricted cash.
• Reliance on a single customer for a significant portion of revenues (12% in Q1 2026, 100% in Q1 2025).

Future Outlook

Management believes it may not have sufficient cash and cash equivalents to maintain planned operations for the next twelve months, raising substantial doubt about its ability to continue as a going concern. Future plans include generating cash through financing transactions, potentially common stock offerings, but these are subject to market conditions and are not deemed probable. The company expects to continue incurring net losses and using cash in operations in the foreseeable future. The strategic focus has shifted to delivering AI tools to the healthcare industry, with new development work concentrated on this area.

Management Comments

• Management believes that it may not have sufficient cash and cash equivalents to maintain the Company's planned operations for the next twelve months following the issuance of these condensed financial statements.
• Management plans include generating cash by completing financing transactions, which may include offerings of common stock. However, these plans are subject to market conditions, and are not within the Company's control, and therefore, cannot be deemed probable.
• Management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.
• We have strongly pivoted to growing our customer base while reducing risk and losses, resulting in a larger client base, a short-term reduction in overall revenue and a dramatic reduction in cash burn.
• Larger, cash-upfront deals were struggling to produce sustainable revenue, as administrative barriers within nonprofits, high price points set by customers, and inability or unwillingness of customers to partner with schools, businesses and other entities to purchase products hampered growth.
• We continue to believe that AI-powered programs, priced affordably, will supplant other academic products in the mid to long term, but have defocused on securing academic customers, and are now offering solutions for the healthcare industry.
• We have focused all new development work on delivering AI tools to markets hungry for increased capability that immediately impacts both their performance and their bottom line. The NurseMagicTM app is the first of these and has already gained traction with larger entities.

Industry Context

Amesite's strategic pivot from academic customers to AI-driven healthcare solutions, exemplified by the NurseMagic™ app, aligns with broader industry trends of increasing demand for specialized AI tools and digital transformation in healthcare. This move positions the company to capitalize on the growing market for AI-powered efficiency and patient care solutions, a sector experiencing significant investment and innovation. The shift away from struggling 'cash-upfront' academic deals suggests an adaptation to market realities and a focus on more sustainable revenue models within a high-growth vertical.

Comparison to Industry Standards

• NA

Related Party Transactions

• Stock-based compensation, including deferred stock units and restricted stock units, were awarded to Board members.

Stakeholder Impact

• Shareholders face potential dilution from future common stock offerings and significant uncertainty regarding the company's ability to continue as a going concern.
• Employees may experience further headcount adjustments as the company continues to streamline operations, though the pivot to healthcare AI could create new opportunities.
• Customers in the healthcare sector, particularly those using the NurseMagic™ app, may benefit from enhanced AI-driven solutions and improved performance.
• Creditors face increased risk due to the company's 'going concern' warning and reliance on future financing.

Next Steps

• Generate cash by completing financing transactions, potentially including offerings of common stock.
• Continue development and market penetration of AI-driven healthcare solutions, such as the NurseMagic™ app.
• Monitor and manage cash and cash equivalents to maintain planned operations for the next twelve months.

Key Dates

Recommendation

Despite significant improvements in revenue growth and reduced net losses, the explicit 'going concern' warning from management, coupled with the uncertainty of future financing and a history of net losses, presents a high level of risk. The company's ability to fund operations for the next twelve months is in doubt, and while the strategic pivot to healthcare AI is promising, it is too early to mitigate the immediate financial instability. A seasoned investor would likely view the substantial doubt about the company's ability to continue as a going concern as a critical red flag, warranting a 'sell' recommendation to avoid potential further capital erosion.

Keywords

AI-driven solutions, healthcare app, NurseMagic, SaaS, education technology, SEC filing, quarterly report, financial results, going concern, capital raise, operating loss, revenue growth